Eckert & Ziegler : has repurchased 125,000 of its own shares as part of its public share buyback offer
May 22, 2018 at 01:10 pm EDT
Share
DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Share Buyback
Eckert & Ziegler has repurchased 125,000 of its own shares as part of its public share buyback offer
22-May-2018 / 19:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Berlin, May 22, 2018 - As part of the voluntary public share buyback offer of Eckert & Ziegler Strahlen- und Medizintechnik AG (hereinafter also referred to as the "Company"), the Company has been tendered a total of 1,189,100 shares until the expiration of the Acceptance Period. The offer of Eckert & Ziegler Strahlen- und Medizintechnik AG amounted to up to 125,000 bearer shares of the Company (ISIN DE0005659700/WKN 565 970) with a total volume of EUR 4.75 million. This represents approx. 2.36 percent of the share capital of the Company. Since a total of 1,189,100 shares were tendered within the Acceptance Period, not all acceptance declarations could be accepted in full. Each acceptance declaration was therefore uniformly reduced by approximately 89.5 %. The tendered shares are expected to be derecognized by the custodian banks against credit of the offer price from the custody accounts by May 25, 2018.
Following this public share buyback offer, the Company now holds a total of 129,818 own shares, including the 4,818 shares already held, representing 2.45 % of the registered share capital.
22-May-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language:
English
Company:
Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone:
49 30 941084-138
Fax:
49 30 941084-112
E-mail:
karolin.riehle@ezag.de
Internet:
www.ezag.de
ISIN:
DE0005659700
WKN:
565970
Listed:
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
ECKERT & ZIEGLER SE 
